ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 81 filers reported holding ONCTERNAL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,800 | -13.0% | 6,000 | 0.0% | 0.00% | – |
Q2 2023 | $2,070 | -67.2% | 6,000 | -25.3% | 0.00% | – |
Q1 2023 | $6,305 | -10.7% | 8,032 | +13.8% | 0.00% | – |
Q4 2022 | $7,060 | +17.7% | 7,060 | +0.9% | 0.00% | – |
Q3 2022 | $6,000 | -57.1% | 7,000 | -45.5% | 0.00% | – |
Q2 2022 | $14,000 | -69.6% | 12,848 | -61.3% | 0.00% | – |
Q1 2022 | $46,000 | -69.1% | 33,217 | -49.4% | 0.00% | – |
Q4 2021 | $149,000 | -38.2% | 65,608 | +13.5% | 0.00% | – |
Q3 2021 | $241,000 | -8.4% | 57,829 | +4.6% | 0.00% | – |
Q2 2021 | $263,000 | +57.5% | 55,306 | +175.2% | 0.00% | – |
Q1 2021 | $167,000 | +475.9% | 20,100 | +235.0% | 0.00% | – |
Q4 2020 | $29,000 | +190.0% | 6,000 | -0.4% | 0.00% | – |
Q3 2020 | $10,000 | -41.2% | 6,024 | +0.4% | 0.00% | – |
Q2 2020 | $17,000 | +13.3% | 6,000 | +20.0% | 0.00% | – |
Q1 2020 | $15,000 | -62.5% | 5,000 | -50.1% | 0.00% | – |
Q4 2019 | $40,000 | -64.3% | 10,015 | -55.4% | 0.00% | – |
Q3 2019 | $112,000 | -41.7% | 22,443 | -22.1% | 0.00% | – |
Q2 2019 | $192,000 | – | 28,821 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Richmond Brothers, Inc. | 494,042 | $148,212 | 0.28% |
Quantum Private Wealth, LLC | 459,187 | $137,757 | 0.07% |
Pasadena Private Wealth, LLC | 278,750 | $83,625 | 0.02% |
Beta Wealth Group, Inc. | 32,000 | $9,600 | 0.01% |
BRIGHTON JONES LLC | 338,491 | $101,548 | 0.01% |
Balboa Wealth Partners | 47,500 | $14,250 | 0.01% |
Waypoint Capital Advisors, LLC | 26,271 | $7,882 | 0.00% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 53,554 | $16,243 | 0.00% |
Aureus Asset Management, LLC | 30,211 | $9,063 | 0.00% |
AXXCESS WEALTH MANAGEMENT, LLC | 70,363 | $21,109 | 0.00% |